Published in J Immunol on September 01, 2007
Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther (2009) 3.20
Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs (2010) 1.67
MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci U S A (2007) 1.32
Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs (2009) 1.13
Immunological regulation of neurogenic niches in the adult brain. Neuroscience (2012) 1.07
IL1β induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-κB. Stem Cell Rev (2012) 1.07
RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells. Proc Natl Acad Sci U S A (2009) 1.05
Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents. PLoS One (2011) 0.96
Comparison of Gene Expression in Human Embryonic Stem Cells, hESC-Derived Mesenchymal Stem Cells and Human Mesenchymal Stem Cells. Stem Cells Int (2011) 0.91
Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies. Biologics (2008) 0.87
A method to generate human mesenchymal stem cell-derived neurons which express and are excited by multiple neurotransmitters. Biol Proced Online (2008) 0.87
Investigational agents for treatment of traumatic brain injury. Expert Opin Investig Drugs (2015) 0.84
Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish. Stem Cells Dev (2011) 0.84
Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis. J Neuroimmune Pharmacol (2015) 0.81
Microenvironment at tissue injury, a key focus for efficient stem cell therapy: A discussion of mesenchymal stem cells. World J Stem Cells (2009) 0.81
Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update (2015) 0.80
Suppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer. Int J Med Sci (2014) 0.80
Wound Healing Versus Regeneration: Role of the Tissue Environment in Regenerative Medicine. MRS Bull (2010) 0.78
Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity? Curr Pharmacogenomics Person Med (2010) 0.77
MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury. Front Cell Neurosci (2017) 0.75
Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res (2011) 2.31
Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol (2003) 2.21
Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells (2007) 1.89
Bone marrow failure following severe injury in humans. Ann Surg (2003) 1.82
Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood (2006) 1.79
Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol (2010) 1.76
Oxygen saturation in the bone marrow of healthy volunteers. Blood (2002) 1.58
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity. Mol Ther Nucleic Acids (2013) 1.38
Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells (2005) 1.37
MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci U S A (2007) 1.32
Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz) (2008) 1.28
Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells. J Biol Chem (2009) 1.22
Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS One (2008) 1.22
Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells (2007) 1.20
The impact of a hypercatecholamine state on erythropoiesis following severe injury and the role of IL-6. J Trauma (2005) 1.18
An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev (2007) 1.16
Adrenergic modulation of erythropoiesis following severe injury is mediated through bone marrow stroma. Surg Infect (Larchmt) (2004) 1.15
Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: a model of early cancer progression. Cancer Res (2004) 1.15
β-blockade protection of bone marrow following trauma: the role of G-CSF. J Surg Res (2011) 1.06
Dose-response relationship between norepinephrine and erythropoiesis: evidence for a critical threshold. J Surg Res (2010) 1.06
Role of human HGFIN/nmb in breast cancer. Breast Cancer Res (2007) 1.06
Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides. Proc Natl Acad Sci U S A (2005) 1.05
RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells. Proc Natl Acad Sci U S A (2009) 1.05
Does beta blockade postinjury prevent bone marrow suppression? J Trauma (2011) 1.04
SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. Blood (2006) 1.03
Hematopoietic progenitor cell mobilization is mediated through beta-2 and beta-3 receptors after injury. J Trauma (2010) 1.03
Beta-blockade prevents hematopoietic progenitor cell suppression after hemorrhagic shock. Surg Infect (Larchmt) (2011) 1.02
Mesenchymal stem cells in drug/gene delivery: implications for cell therapy. Ther Deliv (2012) 1.02
Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J Neurochem (2009) 1.01
Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy-induced asthma. J Allergy Clin Immunol (2011) 1.00
Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P. Regul Pept (2003) 1.00
Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells. Cancer Res (2004) 0.99
Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci (2004) 0.98
A paradoxical role for IFN-gamma in the immune properties of mesenchymal stem cells during viral challenge. Exp Hematol (2005) 0.97
Bone marrow failure in male rats following trauma/hemorrhagic shock (T/HS) is mediated by mesenteric lymph and modulated by castration. Shock (2006) 0.95
A theoretical simulation of hematopoietic stem cells during oxygen fluctuations: prediction of bone marrow responses during hemorrhagic shock. Shock (2004) 0.95
G-coupled protein receptors and breast cancer progression: potential drug targets. Mini Rev Med Chem (2007) 0.94
Stromal derived growth factor-1alpha as a beacon for stem cell homing in development and injury. Curr Neurovasc Res (2005) 0.94
Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells. Methods Mol Biol (2011) 0.94
A novel model of dormancy for bone metastatic breast cancer cells. Cancer Res (2013) 0.93
Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Sci Rep (2012) 0.92
Synergy between the RE-1 silencer of transcription and NFkappaB in the repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells. J Biol Chem (2007) 0.91
AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells. Am J Cancer Res (2011) 0.91
Stem cells and regenerative medicine: accomplishments to date and future promise. Ther Deliv (2010) 0.90
Exogenous CXCL12 activates protein kinase C to phosphorylate connexin 43 for gap junctional intercellular communication among confluent breast cancer cells. Cancer Lett (2012) 0.90
Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential. Virology (2006) 0.90
Nuclear factor-kappaB is central to the expression of truncated neurokinin-1 receptor in breast cancer: implication for breast cancer cell quiescence within bone marrow stroma. Cancer Res (2007) 0.89
Breast cancer biology: the multifaceted roles of mesenchymal stem cells. J Oncol (2008) 0.89
Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA. J Immunol (2008) 0.88
Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies. Biologics (2008) 0.87
A method to generate human mesenchymal stem cell-derived neurons which express and are excited by multiple neurotransmitters. Biol Proced Online (2008) 0.87
Neurokinin receptors: relevance to the emerging immune system. Arch Immunol Ther Exp (Warsz) (2004) 0.86
The Microenvironmental Effect in the Progression, Metastasis, and Dormancy of Breast Cancer: A Model System within Bone Marrow. Int J Breast Cancer (2012) 0.86
microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis. Curr Cancer Ther Rev (2011) 0.86
Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells. Clin Transl Sci (2011) 0.85
Loss of RE-1 silencing factor in mesenchymal stem cell-derived dopamine progenitors induces functional maturity. Mol Cell Neurosci (2008) 0.84
Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish. Stem Cells Dev (2011) 0.84
Tac1 regulation by RNA-binding protein and miRNA in bone marrow stroma: Implication for hematopoietic activity. Brain Behav Immun (2007) 0.84
Peripheral monocytes and CD4+ cells are potential sources for increased circulating levels of TGF-beta and substance P in autoimmune myelofibrosis. Am J Hematol (2006) 0.84
Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection. Oncol Rev (2011) 0.84
Immunostimulatory effects of mesenchymal stem cell-derived neurons: implications for stem cell therapy in allogeneic transplantations. Clin Transl Sci (2008) 0.83
Nuclear factor-kappaB accounts for the repressor effects of high stromal cell-derived factor-1alpha levels on Tac1 expression in nontumorigenic breast cells. Mol Cancer Res (2007) 0.83
Cancer immunotherapy: accomplishments to date and future promise. Ther Deliv (2013) 0.83
An in vitro method to study the effects of hematopoietic regulators during immune and blood cell development. Biol Proced Online (2007) 0.82
Sex hormones affect bone marrow dysfunction after trauma and hemorrhagic shock. Crit Care Med (2007) 0.82
Breast cancer cell dormancy in bone marrow: potential therapeutic targets within the marrow microenvironment. Expert Rev Anticancer Ther (2010) 0.82
Beta Blockade Protection of Bone Marrow Following Injury: A Critical Link between Heart Rate and Immunomodulation. J Bone Marrow Res (2015) 0.82
Cloning and characterization of the 5' flanking region of the HGFIN gene indicate a cooperative role among p53 and cytokine-mediated transcription factors: relevance to cell cycle regulation. Cell Cycle (2005) 0.82
An in vitro method to select malignant cells from surgical biopsies of breast cancer patients. Biol Proced Online (2005) 0.81
Current advances in the treatment of Parkinson's disease with stem cells. Curr Neurovasc Res (2007) 0.81
Stromal derived growth factor-1alpha: another mediator in neural-emerging immune system through Tac1 expression in bone marrow stromal cells. J Immunol (2007) 0.80
Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: cloning and characterization of neurokinin-2 promoter. J Neuroimmunol (2003) 0.80
Neurokinin receptors as potential targets in breast cancer treatment. Curr Drug Discov Technol (2008) 0.79
The anti-proliferative effect of neurokinin-A on hematopoietic progenitor cells is partly mediated by p53 activating the 5' flanking region of neurokinin-2 receptor. Cell Signal (2005) 0.79
Stromal-derived factor-1alpha induces a non-canonical pathway to activate the endocrine-linked Tac1 gene in non-tumorigenic breast cells. J Mol Endocrinol (2008) 0.79
Feline bone marrow-derived mesenchymal stromal cells (MSCs) show similar phenotype and functions with regards to neuronal differentiation as human MSCs. Differentiation (2012) 0.79
Experimental evidence for bone marrow as a source of nonhematopoietic endometrial stromal and epithelial compartment cells in a murine model. Biol Reprod (2013) 0.79
Analysis of the transfer of circulating microRNA between cells mediated by gap junction. Methods Mol Biol (2013) 0.79
Synergism between fibronectin and transforming growth factor-β1 in the production of substance P in monocytes of patients with myelofibrosis. Leuk Lymphoma (2012) 0.78
Multi- and inter-disciplinary science in personalized delivery of stem cells for tissue repair. Curr Stem Cell Res Ther (2009) 0.78
The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential. Clin Exp Metastasis (2006) 0.78
Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cells. PLoS One (2013) 0.78
Long-term kindled seizures induce alterations in hematopoietic functions: role of serum leptin. Epilepsy Res (2005) 0.78
Effects of kindled seizures upon hematopoiesis in rats. Epilepsy Res (2003) 0.78
Effects of hemispheric lateralization and site specificity on immune alterations induced by kindled temporal lobe seizures. Brain Behav Immun (2002) 0.77
Adult mesenchymal stem cells in neural regeneration and repair: Current advances and future prospects (Review). Mol Med Rep (2011) 0.77
Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells. Curr Pharmacogenomics Person Med (2011) 0.77
Tachykinins and hematopoiesis. Clin Chim Acta (2007) 0.77
Can breast cancer stem cells evade the immune system? Curr Med Chem (2012) 0.77
Inflammatory mediators: Parallels between cancer biology and stem cell therapy. J Inflamm Res (2009) 0.77
Autocrine proliferation of neuroblastoma cells is partly mediated through neurokinin receptors: relevance to bone marrow metastasis. J Neurooncol (2005) 0.77
Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link. J Receptor Ligand Channel Res (2010) 0.77
Amygdaloid kindled seizures can induce functional and pathological changes in thymus of rat: role of the sympathetic nervous system. Neurobiol Dis (2005) 0.77
The immune properties of mesenchymal stem cells. Int J Biomed Sci (2007) 0.77
Recent advances and novel approaches in deriving neurons from stem cells. Mol Biosyst (2009) 0.76
Non-canonical effects of anthrax toxins on haematopoiesis: implications for vaccine development. J Cell Mol Med (2008) 0.76
G protein-coupled receptors in haematopoietic disruption. Expert Opin Biol Ther (2006) 0.76
Neurokinin-A inhibits cell cycle activators in K562 cells and activates Smad 4 through a non-canonical pathway: a novel method in neural-hematopoietic axis. J Neuroimmunol (2008) 0.76
Oncogenic and metastatic properties of preprotachykinin-I and neurokinin-1 genes. Vascul Pharmacol (2006) 0.76
A reporter assay to detect transfer and targeting of miRNAs in stem cell-breast cancer co-cultures. Methods Mol Biol (2012) 0.76